News | April 30, 2008

Breast Surgeons Benefit from Ultrasound-Guidance Portfolio

May 1, 2008 - Hologic Inc. said yesterday at the American Society of Breast Surgeons conference in New York City that U.S. breast surgeons are among the first to realize the benefits of Hologic product integrations stemming from recent company mergers, acquisitions and partnerships.
The Suros Celero spring-loaded, vacuum assisted core biopsy device, SecurMark for Celero biopsy site identifier, MammoSite five-day radiation therapy system and a recent agreement with Mindray Medical International to sell the to DP-6600 digital ultrasonic diagnostic imaging system, allows Hologic to offer a comprehensive ultrasound-guided portfolio to the U.S. breast surgery market.

“With Hologic offering a full line of ultrasound breast care products, we are able to drastically shorten the time it takes from performing an abnormal ultrasound biopsy to giving the patient a diagnosis,” said Thomas Heck, M.D., FACS, medical director of the Samaritan Breast Center in Dayton, Ohio. “The waiting period is sometimes now just one day. This is a huge help in significantly lowering patient anxiety.”

SecurMark biopsy site identifiers are one of Hologic’s newest product releases. SecurMark identifiers use a biocompatible titanium clip surrounded by a bio-absorbable suture-like material designed to minimize marker movement within the biopsy cavity and help visualize the marker under traditionally challenging circumstances in the ultrasound environment. SecurMark site identifiers preliminarily indicates visibility 2-3 weeks after deployment, reportedly making it effective for surgeons in accurately guiding them with wire localization should a follow up lumpectomy be necessary. After four months, the Glycoprene netting surrounding the marker shows no visual evidence and is safely and fully absorbed into the body. SecurMark for Celero site identifiers are available in two shapes to provide differentiating images and the ability to diagnose breast disease independently for multiple biopsy sites in a single breast.

“I like the fact that with the Celero, you can pre-fire directly to the lesion and you know you won’t fire past it,” said Dr. Heck. “It provides me with excellent specimens that our pathologists are very happy with and bleeding has not been an issue. Patient care is enhanced because we can make a definitive diagnosis much quicker. It’s the right thing to do and the way a breast center should operate.”

Quehuong Pham, M.D., general surgeon at Inverness Surgical Associates in Inverness, FL notes that the DP-6600 digital ultrasonic diagnostic imaging system gives breast surgeons the ability to provide comprehensive patient care in their office, without the need to refer patients to radiologists for imaging and possible wire localization for a later surgical procedure.

“I see a significant benefit to what Hologic is offering as an ultrasound package,” Dr. Pham said. “Having the ability to image the breast, easily perform a biopsy and mark the biopsy site, and then also provide disease treatment with the MammoSite radiation therapy system, if necessary, really makes my practice very efficient and offers my patients convenience. Not only does this benefit me with scheduling, but also in planning my surgical cases.”

For more information: www.hologic.com

Related Content

EchoGo uses artificial intelligence (AI) to calculate cardiac ultrasound left ventricular ejection fraction (EF), the most frequently used measurement of heart function, left ventricular volumes (LV) and, for the first time for an AI application, automated cardiac strain.

EchoGo uses artificial intelligence (AI) to calculate cardiac ultrasound left ventricular ejection fraction (EF), the most frequently used measurement of heart function, left ventricular volumes (LV) and, for the first time for an AI application, automated cardiac strain.

News | Cardiovascular Ultrasound | November 14, 2019
November 14, 2019 — Ultromics has received 510(k) clearance from the U.S.
Mindray announced its partnership with Cincinnati Children's Hospital Medical Center, one of the top children's hospitals in the United States
News | Ultrasound Imaging | November 13, 2019
November 13, 2019 – Mindray announced its partnership with...
Using artificial intelligence to predice risk of thyroid cancer on ultrasound.

Using artificial intelligence to predice risk of thyroid cancer on ultrasound.

News | Artificial Intelligence | November 06, 2019
November 6, 2019 — Thyroid nodules are small lumps that form within the thyroid gland and are quite common in the gen
Liver cancer tumor scanning using an MRI
News | Proton Therapy | November 04, 2019
November 4, 2019 – Two new studies support and inform the use of proton radiation therapy to treat patients with hepa
The Konica Minolta Sonimage HS1 hand-carried system is designed for point of care ultrasound (POCUS) use for an immediate, quick look inside the patient. POCUS systems from several vendors are seeing rapid growth.

The Konica Minolta Sonimage HS1 hand-carried system is designed for point of care ultrasound (POCUS) use for an immediate, quick look inside the patient. POCUS systems from several vendors are seeing rapid growth.

Feature | Ultrasound Imaging | October 24, 2019 | Joan Toth
With the miniaturization of technology, improved ease of use, lower system cost, increased portability, and greater
Exact Imaging Receives FDA 510(k) Clearance for Sterile Transperineal Needle Guide
Technology | Ultrasound Imaging | October 24, 2019
Exact Imaging received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Sterile Transperineal Needle...
Advanced Radiation Therapy Upgrades AccuBoost Digital Brachytherapy Platform
News | Brachytherapy Systems, Women's Healthcare | October 23, 2019
At the 2019 American Society for Radiation Oncology (ASTRO) annual meeting, Sept. 15-18 in Chicago, Advanced Radiation...